Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 27, Pages 2598-2600Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMp2032369
Keywords
-
Categories
Ask authors/readers for more resources
On October 22, 2020, on the basis of the results of three phase 3 clinical trials, the FDA approved remdesivir for use in adults and pediatric patients (12 years of age or older and weighing at least 40 kg) for the treatment of Covid-19 requiring hospitalization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available